DX-8951f in Treating Patients With Liver Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1999

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Liver Cancer
Interventions
DRUG

exatecan mesylate

Trial Locations (4)

10021

Memorial Sloan-Kettering Cancer Center, New York

78229

Cancer Therapy & Research Center, San Antonio

80262

University of Colorado Cancer Center, Denver

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00004108 - DX-8951f in Treating Patients With Liver Cancer | Biotech Hunter | Biotech Hunter